Last reviewed · How we verify
covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age patent landscape — cliff calendar, originator estates, attackable patents
- covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age treatment landscape brief
- covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age treatment updates RSS
Related
- Treatment landscape: covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age patent cliff · covid 19 vaccine mrna based bivalent xbb 1 5 and original strain intramuscular injection 0 3 ml dose 0 3 ml dose for 6 11 years of age 0 3 ml dose for 5 11 years of age 0 3 ml dose for 6 months 4 years of age 0 3 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age 0 2 ml dose for 6 months 4 years of age CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing